Earth Science Tech, Inc. (OTC: ETST) reported a 57% increase in net income for its fiscal first quarter of 2027, according to results released by the company. Net income rose to $715,697, up from the prior-year period, on revenue of $9.0 million, a 3% increase. The company's gross profit reached $6.3 million, and operating cash flow more than doubled to $707,131. Total assets increased to $10.4 million, reflecting the company's continued growth and financial stability.
Diluted earnings per share improved to $0.003 from $0.001, while the company repurchased and retired more than 3.7 million common shares during the quarter without incurring additional debt. This move signals management's confidence in the company's financial position and its commitment to enhancing shareholder value.
The company stated that all key operating subsidiaries remained profitable during the quarter. Earth Science Tech continues to expand the licensing footprint of its compounding pharmacy operations across the United States, a strategic move that positions the company for further market penetration. Additionally, management is evaluating opportunities to broaden its telehealth and pharmacy fulfillment platforms, which could open new revenue streams and improve patient access to its services.
Management will discuss these results and strategic initiatives at its annual shareholder meeting scheduled for Aug. 31, 2026. At the meeting, investors will vote on proposals including the cancellation of the company's Series B Preferred Stock. This proposal, if approved, could simplify the company's capital structure and potentially make it more attractive to a broader range of investors.
The company also provided updates on a potential exchange uplisting, which aims to improve liquidity and market visibility. An uplisting to a national exchange could enhance the company's profile among institutional investors and potentially increase trading volume, benefiting current shareholders.
Earth Science Tech operates as a diversified holding company focused on the health and wellness sector. Its principal operating strategy is to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The company's healthcare operations are supported by investments in real estate and asset management activities, as well as a consumer products business. The core of the company's value proposition is the seamless integration of patient care, from consultation to fulfillment, achieved through the synergy of its specialized subsidiaries.
The positive financial results and strategic initiatives underscore the company's growth trajectory and its commitment to delivering value to its shareholders. With a strong balance sheet and expanding operational capabilities, Earth Science Tech is well-positioned to capitalize on opportunities in the health and wellness market.
For more information, visit the company's newsroom at https://ibn.fm/ETST.
